AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23131207 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 380
Study 16020626 — intervention group
Group type: EXPERIMENTAL
Intervention: Small group intervention (educational content on diabetes self-management and discussion of attitudes, feelings, and motivations)
Number of subjects: 0
Study 16020626 — intervention group
Group type: COMPARATOR
Intervention: Diabetes self-care book (control group)
Number of subjects: 0
Study 12413434 — intervention group
Group type: EXPERIMENTAL
Intervention: Staphylococcus toxoid (SB) injections (0.1 ml to 1.0 ml weekly for 6 months)
Number of subjects: 100
Study 12413434 — intervention group
Group type: EXPERIMENTAL
Intervention: Staphylococcus toxoid (SB) injections
Number of subjects: 100
Study 12413434 — intervention group
Group type: COMPARATOR
Intervention: Placebo (coloured sterile water)
Number of subjects: 100
Study 10214601 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% povidone-iodine pledget
Number of subjects: 5
Study 10214601 — intervention group
Group type: COMPARATOR
Intervention: 10% povidone-iodine swabstick
Number of subjects: 5
Study 10214601 — intervention group
Group type: COMPARATOR
Intervention: 10% povidone-iodine gauze pad
Number of subjects: 5
Study 7824114 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial color‐coded real‐time sonography (TCCS) in severely affected PD patients
Number of subjects: 30
Study 7824114 — intervention group
Group type: COMPARATOR
Intervention: Transcranial color‐coded real‐time sonography (TCCS) in remaining PD patients and controls
Number of subjects: 30
Study 7824114 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of echogenicity with severity and duration of PD
Number of subjects: 30
Study 7824114 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased echogenicity of the substantia nigra
Number of subjects: 30
Study 1699088 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin treatment during cardiopulmonary bypass
Number of subjects: 0
Study 1699088 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment during cardiopulmonary bypass
Number of subjects: 0
Study 113627 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary radiation (Gp R)
Number of subjects: 55
Study 113627 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary surgery (Gp S)
Number of subjects: 55
Study 113627 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiation of 4000 rads in four weeks (Gp R/S)
Number of subjects: 55
Study 113627 — intervention group
Group type: EXPERIMENTAL
Intervention: Further treatment attempts after initial therapy (Gp R)
Number of subjects: 55
Study 113627 — intervention group
Group type: EXPERIMENTAL
Intervention: Further treatment attempts after initial therapy (Gp S)
Number of subjects: 55
Study 113627 — intervention group
Group type: EXPERIMENTAL
Intervention: Further treatment attempts after initial therapy (Gp R/S)
Number of subjects: 55
Study 113627 — intervention group
Group type: COMPARATOR
Intervention: Postoperative complications in primary radiation failures
Number of subjects: 55
Study 31896121 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of plasma ammonia concentration
Number of subjects: 322
Study 31896121 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein intake (total and intravenous)
Number of subjects: 322
Study 29705931 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased in-degree centrality
Number of subjects: 0
Study 29705931 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased betweenness centrality
Number of subjects: 0
Study 29705931 — intervention group
Group type: EXPERIMENTAL
Intervention: Network position
Number of subjects: 0
Study 29119726 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotrimoxazole (CTX) prophylaxis
Number of subjects: 220
Study 29119726 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study 25547632 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive and motor stimulation interventions (CMSI) administered by a single care provider
Number of subjects: 84
Study 25547632 — intervention group
Group type: COMPARATOR
Intervention: Standard support
Number of subjects: 84
Study 23399084 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 0
Study 23399084 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dexamethasone pulses plus mycophenolate mofetil
Number of subjects: 0
Study 23399084 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 21937380 — intervention group
Group type: EXPERIMENTAL
Intervention: Transoral incisionless fundoplication (TIF), n=34
Number of subjects: 52
Study 21937380 — intervention group
Group type: COMPARATOR
Intervention: Nissen laparoscopic fundoplication (NLF), n=18
Number of subjects: 52
Study 18431216 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventriculoperitoneal shunt surgery
Number of subjects: 647
Study 17179108 — intervention group
Group type: EXPERIMENTAL
Intervention: MSD-SCT
Number of subjects: 191
Study 17179108 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 191
Study 17179108 — intervention group
Group type: EXPERIMENTAL
Intervention: MUD/MMFD-SCT
Number of subjects: 191
Study 14604055 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental practice group
Number of subjects: 35
Study 14604055 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical practice group
Number of subjects: 35
Study 14604055 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study 11076325 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-day antibiotic therapy
Number of subjects: 73
Study 11076325 — intervention group
Group type: COMPARATOR
Intervention: 7-day antibiotic therapy
Number of subjects: 73
Study 9103686 — intervention group
Group type: EXPERIMENTAL
Intervention: Microgynon (combined pill)
Number of subjects: 1076
Study 9103686 — intervention group
Group type: EXPERIMENTAL
Intervention: Depo-Provera
Number of subjects: 1076
Study 9103686 — intervention group
Group type: EXPERIMENTAL
Intervention: CuT 380A (IUCD)
Number of subjects: 1076
Study 1568716 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 million units of recombinant interferon‐alpha three times weekly for 12 weeks
Number of subjects: 28
Study 1568716 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 28
Study 3908782 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) infusion
Number of subjects: 17
Study 3908782 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 31941260 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin (1mg intravenous drip or static push every 6-12 hours for more than 5 days)
Number of subjects: 111
Study 31941260 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (control group)
Number of subjects: 111
Study 31941260 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin in RA-AKI subgroup
Number of subjects: 111
Study 31941260 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin in RA-NAKI subgroup
Number of subjects: 111
Study 29866141 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief cognitive behavioral therapy (CBT)
Number of subjects: 18
Study 29866141 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptations to brief CBT
Number of subjects: 18
Study 29866141 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic relationship and individual patient factors
Number of subjects: 18
Study 29866141 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptations to EBP delivery
Number of subjects: 18
Study 27153076 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergonomic intervention (details on dosage and duration not specified)
Number of subjects: 100
Study 27153076 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergonomic intervention
Number of subjects: 100
Study 27153076 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study 24258770 — intervention group
Group type: EXPERIMENTAL
Intervention: Seated condition tracing task
Number of subjects: 2
Study 24258770 — intervention group
Group type: COMPARATOR
Intervention: Standing condition tracing task
Number of subjects: 2
Study 24258770 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer from standing to seated condition
Number of subjects: 2
Study 24258770 — intervention group
Group type: COMPARATOR
Intervention: Training in standing condition
Number of subjects: 2
Study 21715139 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) applied for 13 days (interquartile range, 7‐30 days) on brachial biceps and vastus medialis (quadriceps) of 1 side of the body.
Number of subjects: 16
Study 20350036 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy for depressed adolescents (IPT‐A)
Number of subjects: 63
Study 20350036 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 63
Study 18479353 — intervention group
Group type: COMPARATOR
Intervention: Exercise (resistive exercise every 3 days)
Number of subjects: 25
Study 18479353 — intervention group
Group type: COMPARATOR
Intervention: Pamidronate (60 mg intravenously, 2 weeks before bed rest)
Number of subjects: 25
Study 18479353 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 25
Study 18479353 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate (60 mg)
Number of subjects: 25
Study 18479353 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (resistive exercise)
Number of subjects: 25
Study 15854173 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.4 g/day of mesalazine
Number of subjects: 156
Study 15854173 — intervention group
Group type: COMPARATOR
Intervention: 1.2 g/day of mesalazine
Number of subjects: 156
Study 12416944 — intervention group
Group type: EXPERIMENTAL
Intervention: Next-day care at the study site's primary care center
Number of subjects: 156
Study 12416944 — intervention group
Group type: COMPARATOR
Intervention: Usual same-day care
Number of subjects: 156
Study 12416944 — intervention group
Group type: EXPERIMENTAL
Intervention: Next-day care
Number of subjects: 156
Study 10604820 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotrimoxazole (TMP/SMX) 4 mg/kg TMP/20 mg/kg SMX at two divided doses for 5 days
Number of subjects: 68
Study 8949315 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril
Number of subjects: 1679
Study 8949315 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1679
Study 1685572 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release remoxipride (REM-CR), 361 mg daily
Number of subjects: 150
Study 1685572 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate-release remoxipride (REM-IR), 332 mg daily
Number of subjects: 150
Study 1685572 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol, 12.5 mg daily
Number of subjects: 150
Study 7235372 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 ppm ozone exposure for 5 consecutive days
Number of subjects: 24
Study 7235372 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 ppm ozone exposure
Number of subjects: 24
Study 7235372 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone exposure
Number of subjects: 24
Study 31780765 — intervention group
Group type: EXPERIMENTAL
Intervention: Amfepramone (AFP) 75 mg single dose
Number of subjects: 36
Study 31780765 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic variants ABCB1‐rs1045642 and CYP3A4‐rs2242480
Number of subjects: 36
Study 31780765 — intervention group
Group type: EXPERIMENTAL
Intervention: ABCB1 and CYP3A4 gene polymorphisms
Number of subjects: 36
Study 29158669 — intervention group
Group type: EXPERIMENTAL
Intervention: Senior meetings
Number of subjects: 416
Study 29158669 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 416
Study 26350480 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RIC)
Number of subjects: 494
Study 26350480 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 494
Study 23551037 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-based intervention with booster during the fall semester
Number of subjects: 1900
Study 23551037 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-based intervention prior to college matriculation
Number of subjects: 1900
Study 23551037 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-based intervention after college matriculation
Number of subjects: 1900
Study 21823222 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-low-fat diet (VLFD; 11% of energy as fat)
Number of subjects: 59
Study 21823222 — intervention group
Group type: EXPERIMENTAL
Intervention: Step 1 diet supplemented with soy food (SFD; 50 mg isoflavones per day)
Number of subjects: 59
Study 21823222 — intervention group
Group type: COMPARATOR
Intervention: Control Step 1 diet (CD; 27% energy as fat) with no SFD
Number of subjects: 59
Study 19356986 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-magnitude mechanical signals (LMMS) at 30Hz for 10min/day, peak-to-peak acceleration magnitudes of 0.3g (n=12) or 0.5g (n=6)
Number of subjects: 33
Study 19356986 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-magnitude mechanical signals (LMMS)
Number of subjects: 33
Study 19356986 — intervention group
Group type: COMPARATOR
Intervention: Control group (CTRs)
Number of subjects: 33
Study 17410108 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid stenting
Number of subjects: 7000
Study 17410108 — intervention group
Group type: COMPARATOR
Intervention: Carotid endarterectomy
Number of subjects: 7000
Study 15485438 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 866
Study 15485438 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 866
Study 11528571 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular pertussis (AP) vaccine
Number of subjects: 199
Study 11528571 — intervention group
Group type: COMPARATOR
Intervention: Licensed meningococcal vaccine (MN)
Number of subjects: 199
Study 9850804 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical-acoustic stimulation (OAS)
Number of subjects: 30
Study 9850804 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation (ES)
Number of subjects: 30
Study 9850804 — intervention group
Group type: COMPARATOR
Intervention: Rest
Number of subjects: 30
Study 9850804 — intervention group
Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 30
Study 8031160 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX/5-FU with 5'-DFUR (group A)
Number of subjects: 75
Study 8031160 — intervention group
Group type: COMPARATOR
Intervention: MTX/5-FU without 5'-DFUR (group B)
Number of subjects: 75
Study 2656264 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother present during induction of anaesthesia
Number of subjects: 49
Study 2656264 — intervention group
Group type: COMPARATOR
Intervention: No parent present during induction of anaesthesia
Number of subjects: 49
Study 31140654 — intervention group
Group type: EXPERIMENTAL
Intervention: Day-and-night hybrid closed-loop insulin delivery using Cambridge FlorenceM system
Number of subjects: 20
Study 30116118 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive training
Number of subjects: 30
Study 30116118 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-limb muscular strength training
Number of subjects: 30
Study 30116118 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 27310328 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg once daily)
Number of subjects: 24
Study 27310328 — intervention group
Group type: COMPARATOR
Intervention: 2D regimen (ombitasvir/paritaprevir/ritonavir 25/150/100 mg once daily)
Number of subjects: 24
Study 27310328 — intervention group
Group type: COMPARATOR
Intervention: 3D regimen (ombitasvir/paritaprevir/ritonavir and dasabuvir 250 mg twice daily)
Number of subjects: 24
Study 24742978 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month implementation intervention
Number of subjects: 128
Study 24742978 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 128
Study 22653713 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of calcium (as calcium carbonate)
Number of subjects: 450
Study 22653713 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg of calcium
Number of subjects: 450
Study 22653713 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 450
Study 20460997 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.4, 0.6, and 0.8 ng/ml) as an adjunct to propofol-based TIVA
Number of subjects: 44
Study 20460997 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.6-0.8 ng/ml) as an adjunct to propofol-based TIVA
Number of subjects: 44
Study 18822980 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) group
Number of subjects: 110
Study 18822980 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 110
Study 15699227 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein containing isoflavones
Number of subjects: 23
Study 15699227 — intervention group
Group type: COMPARATOR
Intervention: Tablets containing extracted soy isoflavones
Number of subjects: 23
Study 11318020 — intervention group
Group type: EXPERIMENTAL
Intervention: Consecutive heat exposure (10 consecutive days)
Number of subjects: 14
Study 11318020 — intervention group
Group type: COMPARATOR
Intervention: Intermittent heat exposure (10 sessions over 3 weeks)
Number of subjects: 14
Study 11318020 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 14
Study 8996743 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g cefotiam + 500 mg metronidazole
Number of subjects: 60
Study 8996743 — intervention group
Group type: COMPARATOR
Intervention: 2 g cefotiam + 500 mg metronidazole
Number of subjects: 60
Study 8996743 — intervention group
Group type: COMPARATOR
Intervention: 2 g cefotiam
Number of subjects: 60
Study 8487059 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate-release morphine (IRM) solution (20 mg/mL)
Number of subjects: 34
Study 8487059 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release morphine (SRM) formulation (30 mg)
Number of subjects: 34
Study 8487059 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IRM and SRM
Number of subjects: 34
Study 3122629 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous diltiazem
Number of subjects: 20
Study 3122629 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 2512801 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate weight gain (4-6 g.kg-1.d-1) - MG group
Number of subjects: 22
Study 2512801 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid weight gain (12-16 g.kg-1.d-1) - RG group
Number of subjects: 22
Study 31287736 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine-assisted self-management program
Number of subjects: 115
Study 31287736 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 115
Study 29101843 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral and mindfulness-based group sleep intervention (n = 63)
Number of subjects: 123
Study 29101843 — intervention group
Group type: COMPARATOR
Intervention: Active control 'study skills' intervention (n = 60)
Number of subjects: 123
Study 26116326 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 16
Study 26116326 — intervention group
Group type: EXPERIMENTAL
Intervention: Left lateral position
Number of subjects: 16
Study 26116326 — intervention group
Group type: COMPARATOR
Intervention: Right lateral position
Number of subjects: 16
Study 26116326 — intervention group
Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 16
Study 24237916 — intervention group
Group type: EXPERIMENTAL
Intervention: Ask-Advise-Connect (AAC) approach
Number of subjects: 0
Study 24237916 — intervention group
Group type: COMPARATOR
Intervention: Ask-Advise-Refer (AAR) approach
Number of subjects: 0
Study 20936482 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal glycemic control (HbA1c <7%, n = 6)
Number of subjects: 30
Study 20936482 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor glycemic control (HbA1c ≥7%, n = 6)
Number of subjects: 30
Study 20936482 — intervention group
Group type: COMPARATOR
Intervention: T1DM subjects
Number of subjects: 30
Study 20936482 — intervention group
Group type: EXPERIMENTAL
Intervention: All subjects
Number of subjects: 30
Study 19223278 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose aerobic exercise (20 min/day)
Number of subjects: 207
Study 19223278 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose aerobic exercise (40 min/day)
Number of subjects: 207
Study 19223278 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 207
Study 16704894 — intervention group
Group type: EXPERIMENTAL
Intervention: Holmium laser enucleation of the prostate (HoLEP)
Number of subjects: 61
Study 16704894 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 61
Study 14679493 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Cycle of Breathing Techniques (ACBT)
Number of subjects: 10
Study 14679493 — intervention group
Group type: COMPARATOR
Intervention: High-Frequency Chest Compressions (HFCC)
Number of subjects: 10
Study 11311035 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified instruction (verbalizing sorting strategy)
Number of subjects: 73
Study 11311035 — intervention group
Group type: COMPARATOR
Intervention: Standard instruction
Number of subjects: 73
Study 9010986 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolasetron mesilate 1.8 mg/kg
Number of subjects: 226
Study 9010986 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolasetron mesilate 1.2 mg/kg
Number of subjects: 226
Study 9010986 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide 7 mg/kg
Number of subjects: 226
Study 9010986 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolasetron mesilate
Number of subjects: 226
Study 9010986 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide
Number of subjects: 226
Study 8054248 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.80 g/kg body weight)
Number of subjects: 12
Study 3396546 — intervention group
Group type: EXPERIMENTAL
Intervention: Halothane anaesthesia
Number of subjects: 20